论文信息 - A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations - 字舞流文

A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations

R. Govindan | R. Suresh | D. Morgensztern | P. Oppelt | Haeseong Park | S. Waqar | N. Wu | M. Baggstrom | S. Devarakonda | B. Pellini | Luke Verghese